Scalable GMP compliant suspension culture system for human ES cells.
about
Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeuticsA massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytesDevelopment of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells.Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture SystemsHuman pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.Cleavage of E-cadherin and β-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cellsA Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem CellsEfficient generation of hPSC-derived midbrain dopaminergic neurons in a fully defined, scalable, 3D biomaterial platform.Cis-acting single nucleotide polymorphisms alter MicroRNA-mediated regulation of human brain-expressed transcriptsA 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell productionDevelopmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation.cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013Development of stem cell-based therapy for Parkinson's disease.Hydrodynamic modulation of pluripotent stem cellsMapping Human Pluripotent-to-Cardiomyocyte Differentiation: Methylomes, Transcriptomes, and Exon DNA Methylation "Memories".In vitro cardiac tissue models: Current status and future prospects.Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells.A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation.Enhanced Adipogenic Differentiation of Human Adipose-Derived Stem Cells in an In Vitro Microenvironment: The Preparation of Adipose-Like Microtissues Using a Three-Dimensional Culture.Magnetic Resonance Imaging of Cardiac Strain Pattern Following Transplantation of Human Tissue Engineered Heart Muscles.Bioprocessing of cryopreservation for large-scale banking of human pluripotent stem cells.Bioreactor design for clinical-grade expansion of stem cells.Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells.Impact of fluidic agitation on human pluripotent stem cells in stirred suspension culture.Cryopreservation: Vitrification and Controlled Rate Cooling.Scaling up a chemically-defined aggregate-based suspension culture system for neural commitment of human pluripotent stem cells.Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System.Developing Defined and Scalable 3D Culture Systems for Culturing Human Pluripotent Stem Cells at High Densities.Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering.Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.Distinctive Roles of Canonical and Noncanonical Wnt Signaling in Human Embryonic Cardiomyocyte Development.Cell fiber-based three-dimensional culture system for highly efficient expansion of human induced pluripotent stem cells.Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.Cryopreservation of pluripotent stem cell aggregates in defined protein-free formulation.Spatial and temporal control of cell aggregation efficiently directs human pluripotent stem cells towards neural commitment.Cardiac differentiation of human pluripotent stem cells in scalable suspension culture.Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective.
P2860
Q26825384-653F9C33-D683-47D8-AC62-F5133CBB2848Q27301270-29EDAEBB-F9D4-453E-A1DB-5830323D38F3Q27303846-ADD144D1-CACC-4819-A763-4227CFE7238DQ27318107-0D45BDF9-FCF4-4F0D-8715-D692B56B19B8Q30395748-AFA915A2-B2E8-415C-8DD5-745158539A89Q30575493-B331DBC1-5F7A-4D6C-A522-1A8B19C38198Q30687945-E9B0B675-54CF-4205-92D9-DEB69872943AQ30835073-949ACDD1-7F5A-4B1B-B4FA-CAB70BA017BFQ33640621-E61E519D-F8D9-4E75-8817-F7F9416125C7Q33730144-4E1DBCB7-3757-4F2C-9BA5-FEA5776286A4Q33822777-E4C2F8A8-138E-486B-B98C-D6A74CED3C8EQ34045021-CB495D63-87E2-4294-B8AE-2A8EAB3F8BE6Q35620068-F36545E4-E10F-4C43-B4E6-1D69DF20B451Q36025246-07018044-156B-4BA1-9A2D-A60FBF2CF204Q36633029-E5235878-A325-4B18-B2F9-C8948310BC9BQ36645680-B8D84D31-06A4-45F6-889E-33C043A958CBQ36801550-89FC9824-2555-4B6C-892B-76A9AF36CA82Q36934047-67C3A06E-B5E4-4C25-863C-AD31DBD83FBCQ37421348-02DAA260-F7C9-4577-AB4B-30B79135EAC7Q37579235-3582D9C5-95EA-4C46-B1A9-E8C181DE0EB0Q37735801-1DDE7E2C-0817-4FA7-896A-EB6713BE0B0CQ38091624-E46E211E-690A-4D6B-8803-B83EDA6123BFQ38102652-A2CDF38D-29B6-4752-82EE-735EA33E0333Q38180213-F46F7AAE-8AE0-4F60-913B-704A9D3D38DFQ38686685-A7C8FD58-50FD-4080-B11D-BB723394DE88Q38709791-9FF465C6-0DF6-47E5-A1CC-25A099A55033Q38809980-8D0297B8-F663-4E9D-9F1A-2B0903C3A320Q38842308-C7E5B123-D438-4E81-92F5-9812DD837462Q38864756-7EB3B15B-C899-41B0-8680-AD50C5CD4654Q39094815-FB6A1C97-CC0A-4C75-A956-AC76ABE77E28Q39144721-CA95A58A-6849-465E-84A0-116093C7FF3EQ39345477-B86F60B1-9D08-4639-849D-126508B74755Q39638005-25E6AD90-A364-407B-B072-41087DDA7DF5Q41456423-1A682401-8C95-4CBA-A8CB-0266A4F2C957Q41869556-2229E2A0-87C5-4757-81AF-BC4230F2078EQ42606543-5F84E0B4-8DF0-443F-8E49-B0003AB7DE4AQ43542912-72FF76DD-B4F9-4731-BE02-0A39AA993AA6Q47717486-BB94140D-143D-4414-B221-CD6D9C157126Q48146853-2FD1F25C-87C6-4B7B-ABBE-AE58E72E4D5EQ50032278-78EBC87F-1263-4652-A6A9-51C30BA41614
P2860
Scalable GMP compliant suspension culture system for human ES cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Scalable GMP compliant suspension culture system for human ES cells.
@en
Scalable GMP compliant suspension culture system for human ES cells.
@nl
type
label
Scalable GMP compliant suspension culture system for human ES cells.
@en
Scalable GMP compliant suspension culture system for human ES cells.
@nl
prefLabel
Scalable GMP compliant suspension culture system for human ES cells.
@en
Scalable GMP compliant suspension culture system for human ES cells.
@nl
P2093
P1433
P1476
Scalable GMP compliant suspension culture system for human ES cells.
@en
P2093
Hsiao-I P Huang
Jingjing Ye
Larry A Couture
Melissa K Carpenter
Sylvana M Couture
Vincent C Chen
Ziguang Lin
P304
P356
10.1016/J.SCR.2012.02.001
P577
2012-02-22T00:00:00Z